Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Drug Retail Industry Analysis

UpdatedMay 20, 2025
DataAggregated Company Financials
Companies1
  • 7D10.7%
  • 3M0%
  • 1Y-18.6%
  • YTDn/a

In the last week, the Drug Retail industry is up 15%, with all of the companies up. However, the industry is down 16% over the past year.

Industry Valuation and Performance

Has the New Zealand Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 20 May 2025NZ$119.2mNZ$513.6mNZ$12.1m9.9x9.9x0.2x
Thu, 17 Apr 2025NZ$104.8mNZ$513.6mNZ$12.1m8.7x8.7x0.2x
Sat, 15 Mar 2025NZ$114.9mNZ$513.6mNZ$12.1m9.5x9.5x0.2x
Mon, 10 Feb 2025NZ$120.6mNZ$513.6mNZ$12.1m10x10x0.2x
Wed, 08 Jan 2025NZ$122.1mNZ$513.6mNZ$12.1m10.1x10.1x0.2x
Fri, 06 Dec 2024NZ$127.8mNZ$513.6mNZ$12.1m10.6x10.6x0.2x
Sun, 03 Nov 2024NZ$109.1mNZ$503.9mNZ$12.0m9.1x9.1x0.2x
Tue, 01 Oct 2024NZ$110.6mNZ$503.9mNZ$12.0m9.2x9.2x0.2x
Thu, 29 Aug 2024NZ$127.8mNZ$503.9mNZ$12.0m10.6x10.6x0.3x
Sat, 27 Jul 2024NZ$129.2mNZ$503.9mNZ$12.0m10.7x10.7x0.3x
Mon, 24 Jun 2024NZ$113.4mNZ$503.9mNZ$12.0m9.4x9.4x0.2x
Wed, 22 May 2024NZ$143.5mNZ$495.9mNZ$13.5m10.6x10.6x0.3x
Fri, 19 Apr 2024NZ$149.2mNZ$495.9mNZ$13.5m11x11x0.3x
Sun, 17 Mar 2024NZ$150.6mNZ$495.9mNZ$13.5m11.1x11.1x0.3x
Tue, 13 Feb 2024NZ$180.8mNZ$495.9mNZ$13.5m13.4x13.4x0.4x
Thu, 11 Jan 2024NZ$162.1mNZ$495.9mNZ$13.5m11.9x12x0.3x
Sat, 09 Dec 2023NZ$143.5mNZ$495.9mNZ$13.5m10.6x10.6x0.3x
Mon, 06 Nov 2023NZ$173.6mNZ$493.6mNZ$15.0m11.6x11.6x0.4x
Wed, 04 Oct 2023NZ$176.5mNZ$493.6mNZ$15.0m11.6x11.8x0.4x
Fri, 01 Sep 2023NZ$186.5mNZ$493.6mNZ$15.0m12.4x12.4x0.4x
Sun, 30 Jul 2023NZ$190.8mNZ$493.6mNZ$15.0m12.7x12.7x0.4x
Tue, 27 Jun 2023NZ$192.2mNZ$493.6mNZ$15.0m12.8x12.8x0.4x
Thu, 25 May 2023NZ$200.6mNZ$715.5mNZ$26.3m7.6x7.6x0.3x
Sat, 22 Apr 2023NZ$193.4mNZ$715.5mNZ$26.3m7.4x7.4x0.3x
Mon, 20 Mar 2023NZ$199.2mNZ$715.5mNZ$26.3m7.6x7.6x0.3x
Wed, 15 Feb 2023NZ$187.7mNZ$715.5mNZ$26.3m7.1x7.1x0.3x
Fri, 13 Jan 2023NZ$192.0mNZ$715.5mNZ$26.3m7.3x7.3x0.3x
Sun, 11 Dec 2022NZ$189.1mNZ$715.5mNZ$26.3m7.2x7.2x0.3x
Tue, 08 Nov 2022NZ$173.4mNZ$670.3mNZ$24.6m7.2x7.1x0.3x
Thu, 06 Oct 2022NZ$189.1mNZ$670.3mNZ$24.6m7.7x7.7x0.3x
Sat, 03 Sep 2022NZ$197.7mNZ$670.3mNZ$24.6m8.1x8.1x0.3x
Mon, 01 Aug 2022NZ$196.3mNZ$670.3mNZ$24.6m8x8x0.3x
Wed, 29 Jun 2022NZ$192.0mNZ$670.3mNZ$24.6m7.8x7.8x0.3x
Fri, 27 May 2022NZ$186.1mNZ$603.2mNZ$17.6m10.6x10.6x0.3x
Price to Earnings Ratio

10.6x


Total Market Cap: NZ$186.1mTotal Earnings: NZ$17.6mTotal Revenue: NZ$603.2mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Drug Retail Industry Price to Earnings3Y Average 9.7x202320242025
Current Industry PE
    There is only one company in the New Zealander Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 12% per year over the last three years,
  • Revenues have also declined 5.2% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does New Zealand Drug Retail compare with similar industries?

NZ Market-0.18%
Consumer Staples1.01%
Food and Staples Retail7.93%
Drug Retail10.67%
Food Retail1.12%
Food Distributors0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GXH Green Cross HealthNZ$0.8310.7%
+NZ$11.5m		-17.0%PE9.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GXH

NZ$0.83

Green Cross Health

7D

10.7%

1Y

-17.0%

Investors Aren't Buying Green Cross Health Limited's (NZSE:GXH) Earnings

May 14
Investors Aren't Buying Green Cross Health Limited's (NZSE:GXH) Earnings